SCHEMBL13870959

SCHEMBL13870959

CCc1cc2ccc(-c3cc(C)ccc3C)nc2cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.43
MAPT P10636 5/20 0.43
MEN1 O00255 5/20 0.43
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 7/20 0.38
TDP1 Q9NUW8 2/20 0.38
ALOX12 P18054 1/20 0.38
KDM4E B2RXH2 2/20 0.38
TLR8 Q9NR97 1/20 0.38
RXFP1 Q9HBX9 1/20 0.37
TP53 P04637 2/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870957 0.88 KMT2A (0.41) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL13870958 0.85 NQO2 (0.35) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL13870905 0.84 CYP1A2 (0.41) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL16487807 0.83 KMT2A (0.40) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL13870949 0.79 KMT2A (0.36) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL13870956 0.78 NUDT1 (0.39) KMT2AMAPTMEN1ALDH1A1TDP1
SCHEMBL13870948 0.78 KMO (0.42) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL13870961 0.78 NPC1 (0.44) MAPTALDH1A1TDP1KDM4ETP53
SCHEMBL13870934 0.76 PDGFRB (0.43) KMT2AMAPTMEN1NPSR1ALDH1A1
SCHEMBL23872164 0.74 CYP1A2 (0.48) KMT2ANPSR1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 KMT2A 2208/4885MAPT 1550/4885MEN1 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.